Discover Opportunities in Auxilo's Financial Growth
INVESTOR RELATIONS
Investor Relation: compliance@auxilo.com
COMPLIANCE & INVESTOR GRIEVANCE OFFICER
Name: Namita Raja
Designation: Chief – Operations, Policy & Control
Address: Auxilo Finserve Pvt. Ltd. Office No. 63, 6th floor, Kalpataru Square, Kondivita Road, Andheri East, Mumbai 400059
Email: compliance@auxilo.com
Phone No.: 022 6246 3333
Debenture Trustee
a) Name: Catalyst Trusteeship Limited
Address: GDA House, First Floor, Plot No. 85
S. No. 94 & 95, Bhusari Colony (Right),
Kothrud Pune MH 411038
Email ID: dt@ctltrustee.com
Phone No: +91 (020) 2528 0081
Registrars to an Issue and Share Transfer Agents (RTAs)
Name: Linkin time
Postal Address: Link Intime India Pvt. Ltd C 101,
Embassy 247, L.B.S.Marg, Vikhroli (West), Mumbai - 400083.
Email ID: mumbai@linkintime.co.in
Phone No: 1800 1020 878
Model Tripartite Agreement with RTA
MARKET LINKED DEBENTURES - VALUATION REPORT
Auxilo Finserve Pvt Ltd. issues Secured, Rated, Listed, Redeemable, Principal Protected, Non-Convertible, Market Linked Debentures (hereinafter referred to as "MLDs"), which are structured debt instruments that have a return linked to the performance of any type of market benchmark that decides the amounts of future coupon payments. Refer to the relevant Offer Documents i.e. Shelf Disclosure Document and Supplemental Disclosure Document relating to the specific MLD issuances for details, including their risk factors.
As per the SEBI Guidelines for Issue and Listing of Structured Products / Market Linked Debentures dated September 28, 2011, CRISIL Limited (CRISIL) has been appointed as the valuation agency for valuation of these MLDs.
Disclosures Under Regulation 62 of LODR
NOTICE & ANNOUNCEMENTS
Financials & Annual Return
| Sr No | Documents | Date | |
|---|---|---|---|
| 1. | Annual Report 2024 - 25 | 2025-Aug |
|
| 2. | Board meeting 30 july 2025 | 2025-Jul |
|
| 3. | Outcome of the Board Meeting held on 30th April 2025 | 2025-Apr |
|
| 4. | Outcome of Board Meeting held on 3rd February 2024 | 2024-Feb |
|
| 5. | Outcome of Board Meeting held on 25th October 2024 | 2024-Oct |
|
| 6. | Outcome Of The Board Meeting - 2nd August 2024 | 2024-Aug |
|
| 7. | Annual Report 2023-24 | 2024-Mar |
|
| 8. | Outcome for Board Meeting March 2024 | 2024-Mar |
|
| 9. | Outcome December 2023 | 2023-Dec |
|
| 10. | Financials June 2023 - Outcome of Board Meeting | 2023-Jun |
|
| 11. | Annual Report FY 2022-23 | 2023-Mar |
|
| 12. | Financials March 2023 | 2023-Mar |
|
| 13. | Financials for Quarter December 2022 | 2022-Dec |
|
| 14. | Financials for half year ended 30th September, 2022 | 2022-Sep |
|
| 15. | Annual Report FY 2021-22 | 2022-Mar |
|
| 16. | Financials for Quarter June 2022 | 2022-Jun |
|
| 17. | Financial Results 19th May 2022 | 2022-May |
|
| 18. | Financial Results for period ended 31.12.2021 | 2021-Dec |
|
| 19. | Half Yearly Un - Audited Financial Results_September, 2021 | 2021-Sep |
|
| 20. | Annual Report FY 2020-21 | 2021-Mar |
|
| 21. | Annual Financial Results and Auditors Report |
|
|
| 22. | Half Yearly un-audited Financial Results_September, 2020 | 2020-Sep |
|
| 23. | Annual Report FY 2019-20 | 2020-Mar |
|
| 24. | Annual Return MGT-7 2023 - 24 | 2024-Mar |
|
| 25. | Annual Return MGT-7 2022 - 23 | 2023-Mar |
|
| 26. | Annual Return MGT-7 2021 - 22 | 2022-Mar |
|
| 27. | Annual Return MGT-7 2020 - 21 | 2021-Mar |
|
Credit Rating
| Sr No | Documents | Date | |
|---|---|---|---|
| 1. | CRISIL Rating Rationale - 30th Mar 2024 | 2024-Mar |
|
| 2. | CRISIL Rating | 2020-Jan |
|
| 3. | CARE Rating Reaffirmed December, 2020 | 2020-Dec |
|
| 4. | CARE Rating February, 2020 | 2020-Feb |
|